Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Figure 2

Western blotting analysis with representative sera recognizing Ezrin recombinant protein. The polyclonal anti-Ezrin antibody was used as positive control; lanes 1–5, five representative ESCC sera (with AJCC stage I, stage II, stage II, stage III, and stage III, resp.) with positive results in ELISA test have strong reactivity with Ezrin recombinant protein in western blotting analysis; lanes 6–10 are five representative normal control sera with negative reactivity.